Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurotherapeutics
Metadata
Title
Ketone bodies as a therapeutic for Alzheimer’s disease
Author
Samuel T. Henderson
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 3/2008
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1016/j.nurt.2008.05.004

Other articles of this Issue 3/2008

Neurotherapeutics 3/2008 Go to the issue

Review Article

New therapeutic targets in the neurovascular pathway in Alzheimer’s disease

Review Article

Targeting β-amyloid pathology in Alzheimer’s disease with Aβ immunotherapy

Abstract

Abstracts from the ASENT 2008 Annual Meeting March 6–8, 2008

Review Article

Therapeutics for Alzheimer’s disease based on the metal hypothesis

Review Article

Inhibition and modulation of γ-secretase for Alzheimer’s disease

Review Article

PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease